Rossini M - Search Results

1

Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database.

Adami G, Gatti D, Rossini M, Giollo A, Gatti M, Bertoldo F, Bertoldo E, Mudano AS, Saag KG, Viapiana O, Fassio A. Adami G, et al. Among authors: rossini m. Bone. 2024 Feb;179:116958. doi: 10.1016/j.bone.2023.116958. Epub 2023 Nov 8. Bone. 2024. PMID: 37949390

2

The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Adami S, Gatti D, Bertoldo F, Rossini M, Fratta-Pasini A, Zamberlan N, Facci E, Lo Cascio V. Adami S, et al. Among authors: rossini m. Osteoporos Int. 1992 Jul;2(4):180-5. doi: 10.1007/BF01623924. Osteoporos Int. 1992. PMID: 1611223

3

The radiological assessment of vertebral osteoporosis.

Adami S, Gatti D, Rossini M, Adamoli A, James G, Girardello S, Zamberlan N. Adami S, et al. Among authors: rossini m. Bone. 1992;13 Suppl 2:S33-6. doi: 10.1016/8756-3282(92)90194-2. Bone. 1992. PMID: 1627412

4

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.

Adami S, Fossaluzza V, Rossini M, Bertoldo F, Gatti D, Zamberlan N, Lo Cascio V. Adami S, et al. Among authors: rossini m. Bone Miner. 1991 Oct;15(1):73-81. doi: 10.1016/0169-6009(91)90111-c. Bone Miner. 1991. PMID: 1747568 Clinical Trial.

5

Transdermal estradiol in the treatment of postmenopausal bone loss.

Adami S, Suppi R, Bertoldo F, Rossini M, Residori M, Maresca V, Lo Cascio V. Adami S, et al. Among authors: rossini m. Bone Miner. 1989 Aug;7(1):79-86. doi: 10.1016/0169-6009(89)90064-0. Bone Miner. 1989. PMID: 2670019 Clinical Trial.

6

The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.

Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R, Lo Cascio V. Adami S, et al. Among authors: rossini m. Bone Miner. 1987 Aug;2(5):395-404. Bone Miner. 1987. PMID: 2975514

7

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.

Rossini M, Gatti D, Zamberlan N, Braga V, Dorizzi R, Adami S. Rossini M, et al. J Bone Miner Res. 1994 Nov;9(11):1833-7. doi: 10.1002/jbmr.5650091121. J Bone Miner Res. 1994. PMID: 7863833 Clinical Trial.

8

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Adami S, Mian M, Gatti P, Rossini M, Zamberlan N, Bertoldo F, Lo Cascio V. Adami S, et al. Among authors: rossini m. Bone. 1994 Jul-Aug;15(4):415-7. doi: 10.1016/8756-3282(94)90818-4. Bone. 1994. PMID: 7917580 Clinical Trial.

9

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.

Adami S, Zamberlan N, Mian M, Dorizzi R, Rossini M, Braga B, Gatti D, Bertoldo F, Locascio V. Adami S, et al. Among authors: rossini m. Bone Miner. 1994 May;25(2):75-82. doi: 10.1016/s0169-6009(08)80249-8. Bone Miner. 1994. PMID: 8086853

10

[The medical treatment of primary hyperparathyroidism].

Lo Cascio V, Rossini M, Bertoldo F. Lo Cascio V, et al. Among authors: rossini m. Recenti Prog Med. 1993 Apr;84(4):287-95. Recenti Prog Med. 1993. PMID: 8488334 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

880 results

Search Page

Filters